SEP 9, 2026 · PHASE 3 TRIAL
A Phase III Study of SHR-A1811 Injection With or Without Pertuzumab in HER2-Positive Recurrent or Metastatic Breast Cancer
ClinicalTrials.gov
This is an active Phase 3 trial registry record with no results posted; the study is ongoing and efficacy and safety data are not yet available for analysis.
Reported
Planned enrollment868
PhasePhase 3
Primary outcome measureProgression Free Survival by Blinded Indepe…